Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma

Published:2013-11-05 Issue:1 Volume:47 Page:46-56
ISSN:0891-6934
Container-title:Autoimmunity
language:en
Short-container-title:Autoimmunity

Author:

Chen Xiaodan,Liu Zhimin,Huang Yunchao,Li Ruilei,Zhang Hongqing,Dong Suwei,Ge Chunlei,Zhang Zhiwei,Wang Ying,Wang Ying,Xue Yuanbo,Li Zhen,Song Xin

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.3109/08916934.2013.850080

Reference46 articles.

1. Global Cancer Statistics, 2002

2. Household Stove Improvement and Risk of Lung Cancer in Xuanwei, China

3. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8+ T cell/regulatory T cells in tumour

4. Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccines

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GADD45B predicts lung squamous cell carcinoma survival and impacts immune infiltration, and T cell exhaustion;Autoimmunity;2023-05-11

2. Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer;Frontiers in Immunology;2022-02-17

3. B7-1 and GM-CSF enhance the anti-tumor immune effect of DC-tumor fusion vaccine in the treatment of prostate cancer;Medical Oncology;2020-11

4. Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model;Immunotherapy;2019-05

5. Antigen-Presenting Cell/Tumour Cell Hybrid Vaccines in Cancer Immunotherapy;Immunotherapy - Myths, Reality, Ideas, Future;2017-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3